AcelRx Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
80.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
1
|
|
# Buys
|
0
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.20
|
-0.94
|
0.26
|
21.67%
|
|
2022-06-30
|
-1.50
|
9.60
|
11.10
|
740.00%
|
|
2022-03-31
|
-1.20
|
-1.20
|
0.00
|
0.00%
|
|
2021-12-31
|
-1.40
|
-1.20
|
0.20
|
14.29%
|
|
2021-09-30
|
-1.40
|
-1.40
|
0.00
|
0.00%
|
|
2021-06-30
|
-1.53
|
-1.60
|
-0.07
|
-4.58%
|
|
2021-03-31
|
-1.67
|
-1.60
|
0.07
|
4.19%
|
|
2020-12-31
|
-2.07
|
-2.00
|
0.07
|
3.38%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
7.46
|
|
2021-12-31
|
-5.80
|
|
2020-12-31
|
-4.28
|
|
2019-12-31
|
-0.67
|
|
2018-12-31
|
-0.82
|
|
2017-12-31
|
-1.11
|
|
2016-12-31
|
-0.95
|
|
2015-12-31
|
-0.56
|
|
2014-12-31
|
-0.91
|
|
2013-12-31
|
-1.02
|
|
2012-12-31
|
-1.50
|
|
2011-12-31
|
-1.18
|
|
2010-12-31
|
-3.64
|